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Abstract We have established a CGR8 embryonic stem (ES)
cell clone (MLC2ECFP) which expresses the enhanced cyan
variant of Aequorea victoria green fluorescent protein (ECFP)
under the transcriptional control of the ventricular myosin light
chain 2 (MLC2v) promoter. Using epifluorescence imaging of
vital embryoid bodies (EB) and reverse transcription-polymerase
chain reaction (RT-PCR), we found that the MLC2v promoter is
switched on as early as day 7 and is accompanied by formation of
cell clusters featuring a bright ECFP blue fluorescence. The
fluorescent areas within the EBs were all beating on day 8.
MLC2ECFP ES cells showed the same time course of cardiac
differentiation as mock ES cells as assessed by RT-PCR of genes
encoding cardiac-specific transcription factors and contractile
proteins. The MLC2v promoter conferred ventricular specificity
to ECFP expression within the EB as revealed by MLC2v co-
staining of ECFP fluorescent cells. MLC2ECFP-derived cardiac
cells still undergo cell division on day 12 after isolation from EBs
but withdraw from the cell cycle on day 16. This ES cell clone
provides a powerful cell model to study the signalling roads of
factors regulating cardiac cell proliferation and terminal
differentiation with a view to using them for experimental cell
therapy. ß 2000 Federation of European Biochemical Soci-
eties. Published by Elsevier Science B.V. All rights reserved.
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1. Introduction
Heart morphogenesis is among the earliest milestones of
organogenesis in vertebrate embryos. Cardiac progenitor cells
derive from mesodermal cells shortly after gastrulation. Sub-
sequent cardiac cell di¡erentiation is then a complex cellular
process that comprises cell proliferation, migration and di¡er-
entiation. Once determined, cardiomyocytes form the linear
heart tube, so-called primary myocardium, one of the earliest
morphogenetic events in the embryo [1]. The cardiac cell is
unique in its ability to commit to a terminally di¡erentiated
muscle phenotype whilst concomitantly undergoing cellular
proliferation. This property is, however, restricted to embry-
onic cardiac cells. Adult cardiomyocytes are locked in the G0
or G1 phase of the cell cycle [2] and are thus terminally di¡er-
entiated. Although the latter dogma has been challenged [3],
loss of contractile cardiomyocytes during aging, after severe
ischemia, or in cardiomyopathies triggers ¢rst a compensatory
cardiac hypertrophy and, then, a failure of cardiac function,
pointing to a limited proliferative capability of adult cardio-
myocytes.
Determinants of the cardiogenic phenotype are still unclear.
However, three major transcription factors of the Nkx,
GATA, and MEF2 families play in concert a preponderant
role in cardiac cell di¡erentiation [4,5]. These factors trans-
activate muscle-speci¢c genes including actin, myosin light
chain (MLC), myosin heavy chain (MHC), troponins and
desmin [1,6]. Little is known about the regulatory mechanisms
including signals of di¡erentiation and growth factors that
arise from the endoderm and which specify or promote the
cardiogenic phenotype. To address such questions in an ‘in
vivo-like’ environment, pluripotent embryonic stem cells (ES
cells) represent a suitable cell system since they recapitulate
programmed expression of cardiac genes characteristic of the
mouse embryo [7,8]. Furthermore, since the establishment of a
human ES cell line [9], engraftment of cardiac-committed stem
cells into the heart [10] has become a very promising and
challenging therapeutic approach to improve the state of a
failing heart. A similar approach with transplanted stem cells
has already turned out to be successful for neurons to rescue
the function of an injured spinal cord [11]. However, to reach
such a goal in cardiology, and to eliminate the risk of uncon-
trolled cell proliferation or of miscommitment, it is mandatory
to study the terminal steps of di¡erentiation of ventricular
cells.
In a pioneering work, Metzger et al. (1996) engineered a D3
ES cell clone, which expresses as a reporter the L-galactosi-
dase gene under the transcriptional control of the K-actin
promoter. More recently, Kolossov et al. [12] established a
similar D3 ES cell clone using green £uorescent protein
(GFP) as a reporter gene. Although the K-actin gene is the
earliest cardiac marker, it is not speci¢c of ventricles or even
of the heart [13,14]. Chamber speci¢cation occurs early during
embryonic heart development. Atrial and ventricular cells
arise from divergent lineages that are determined in the ‘pri-
mary’ myocardium before looping of the heart occurs [15,16].
This ‘time window’ during which ventricular and atrial cells
are already determined but not terminally di¡erentiated can
be used to sort out precursors of one cell population from the
other.
Here, we have engineered and characterized the potential of
a CGR8 ES cell clone in which the enhanced cyan £uorescent
protein (ECFP) is exclusively expressed in cardiac ventricular
cells. These cells provide a suitable model to study the signal-
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ling pathways of growth factors, which regulate ventricular
speci¢cation in an embryonic-like developmental context.
2. Materials and methods
2.1. Plasmid construction
The 250 bp fragment of the MLC2 promoter was excised from a
luciferase expression vector pMLCLv5P [17] and was subcloned into
the HindIII/EcoRI sites of the promoterless pECFP vector (Clontech).
After linearization using the unique XhoI restriction site, the plasmid
was electroporated into CGR8 ES cells (generated from the pluripo-
tent inner cell mass of the preimplantation 129J mouse embryos at the
Centre for Genome Research in Edinburgh) according to the standard
protocol. The ES clones (MLC2ECFP) were propagated in the pres-
ence of leukemia inhibitory factor (LIF) and selected for 10 days
using G418 (250 Wg/ml). Seven neomycin-resistant colonies of ES cells
showing the brightest £uorescence after 9 days of di¡erentiation were
further selected.
2.2. ES cell di¡erentiation
ES CGR8 cells were propagated in BHK21 medium supplemented
with pyruvate, non-essential amino acids, mercaptoethanol, 10% fetal
calf serum [18] and LIF conditioned medium obtained from pre-con-
£uent 740 LIF-D cells that are stably transfected with a plasmid
encoding LIF [19]. The cells were trypsinized and replated every sec-
ond day. Under these conditions, the ES cells feature an undi¡eren-
tiated phenotype (i.e. tightly packed cells forming colonies) as assessed
by daily microscopic observation. Di¡erentiation was carried out us-
ing the hanging drop method [7]. Brie£y, embryoid bodies (EBs) were
formed in hanging drops of di¡erentiation medium (BHK21 medium
supplemented with pyruvate, non-essential amino acids, mercaptoeth-
anol and 20% fetal calf serum without LIF) for 2 days (D0^2). Then,
the EBs were incubated for 3 days in suspension (D2^5) and for 7^15
days on gelatin-coated dishes or glass coverslips (D6^12).
2.3. Cell imaging
Images of EBs or isolated cells were acquired with a Leica epi£uo-
rescence microscope equipped with a 20U, 40U or 100U objective
mounted on a piezo-electric device (LVPZT position servo controller,
Physik Instrumente, Waldbronn, Germany) driven by Metamorph
software (Universal Imaging, USA). To visualize in situ immunostain-
ing of MLC2v, optical z-sectioning of the EBs was carried out using a
0.4 Wm step. To detect ECFP £uorescence, the EBs or isolated cells
were illuminated with a mercury lamp at 400 þ 20 nm and the ECFP
£uorescence recorded with a X114-2 CFP Leica ¢lter cube that con-
sists of a dichroic mirror DM 455 and an emission ¢lter at 480 þ 30
nm. Images were acquired with a micromax 1300YHS CCD camera
(Princeton Instruments, USA) and stored as single ti¡ images or as a
volume ¢le (‘stack’ of z-section images) using the Metamorph. To
improve the resolution and the signal-to-noise ratio of the volume
data, digital deconvolution was applied to ‘stacks’ of images. The
images were restored using Huygens software (Huygens 2.2.1, Scien-
ti¢c Volume Imaging, The Netherlands) and visualized using Imaris
(Bitplane, Switzerland). All calculations were performed using an Oc-
tane workstation (Silicon Graphics).
2.4. Cell immunostaining
EBs of 12^14 days were ¢xed in 3% paraformaldehyde for 45 min
and permeabilized for 30 min with 1% Triton X-100. In some experi-
ments, EBs were dissociated on day 9 with trypsin (0.05% in phos-
phate-bu¡ered saline, EDTA 1 mM) for 5 min at 37‡C or with colla-
genase for 20^30 min at 37‡C (Worthington CLSII, 1 mg/ml) in
HEPES bu¡er adjusted to pH 7.35, containing NaCl 117 mM,
HEPES 20 mM, NaH2PO4 1.2 mM, KCl 5.4 mM, MgSO4 1 mM,
glucose 5 mM. The isolated cells were plated on gelatin-coated glass
coverslips. After 3 days, cells were ¢xed in 3% paraformaldehyde and
permeabilized with 0.5% Triton X-100. Immunostaining was per-
formed as previously described [20]. Polyclonal anti-MLC2a and
anti-MLC2v antibodies were previously characterized [21]. The mono-
clonal anti-ryanodine antibody was from A⁄nity Bioreagents [22].
The anti-mouse and anti-rabbit IgG secondary TRITC-conjugated
antibodies were from Sigma (La Verpille're, France).
2.5. Cell division
Cells isolated from 9- or 13-day-old EBs with collagenase, as de-
scribed above, were plated on gelatin-coated glass coverslips. On day
12 (9+3), or 16 (13+3), bromodeoxyuridine (BrdU) was added for 30
min. After washing and ¢xing, incorporation of BrdU was revealed
using a monoclonal anti-BrdU antibody (Amersham) and a secondary
TRITC-conjugated anti-mouse IgG antibody. Ventricular cells under-
going DNA synthesis were detected by both ECFP £uorescence and
nuclear BrdU staining. To investigate whether ES-derived ventricular
cells were still dividing, cells isolated on day 9 from EBs, and plated
on glass coverslips set in small steel cuvettes, were transferred on day
12 to the stage of the microscope in a small (10 cm diameter) plexi-
glass culture chamber. To maintain a temperature of 37‡C, both the
stage of the microscope and the objective were temperature-con-
trolled. Moreover, heated gas (95% O2/5% CO2) was pulsed by a
minipump into the chamber. ECFP £uorescent images were captured
with the CCD camera every 4 h for 3 days using the time-lapse mode
of the Metamorph software.
2.6. Reverse transcription-polymerase chain reaction (RT-PCR)
Total RNA was extracted by a modi¢ed phenol^chloroform meth-
od from 10 EBs lysed in guanidinium thiocyanate-containing bu¡er
[23,24]. After reverse transcription, 100^300 ng RNA was used for
PCR to stay within the linear range of ampli¢cation. PCR was carried
out using a set of gene-speci¢c primers (GATA4, sense 5P-CGA-
GATGGGACGGGACACT-3P, antisense 5P-CTCACCCTCGGCCA-
TTACGA-3P ; Nkx2.5, sense 5P-TGCAGAAGGCAGTGGAGCTG-
GACAAGCC-3P, antisense 5P-TGCACTTGTAGCGACGGTTCTG-
GAACCAG-3P ; MEF2C, sense 5P-AGCAAGAATACGATGCCA-
TC-3P, antisense 5P-GAAGGGGTGGTGGTACGGTC-3P ; LMHC,
sense 5P-GCCAACACCAACCTGTCCAAGTTC-3P, antisense 5P-CT-
GCTGGAGAGGTTATTCCTCG-3P ; MLV2v, sense 5P-GCCAAG-
AAGCGGATAGAAG G-3P, antisense 5P-CTGTGGTTCAGGGCT-
CAGTC-3P ; tubulin, sense 5P-TCACTGTGCCTGAACTTACC-3P,
antisense 5P-GGAACATAGCCGTAAACTGC-3P) as previously de-
scribed [24]. Tubulin, studied as a housekeeping gene to check
the amount of RNA used in each RT-PCR, LMHC, GATA4 and
MLC2v cDNA were ampli¢ed for 30 cycles. Nkx2.5 and MEF2
cDNA were ampli¢ed for 30^36 cycles. The PCR products were an-
alyzed in agarose gel electrophoresis and the ethidium bromide-
stained bands were quanti¢ed by scanning photographs of gels using
a CCD camera and the Image J 1.01 software (NIH, USA). The
nature of PCR products was checked by size and in some cases by
restriction analysis or sequencing.
3. Results
We established a CGR8 cell line by transfecting ES cells
with a construct composed of the 250 bp MLC2v promoter
upstream of the ECFP cDNA. The clones were selected for 10
days with G418. To ensure that ECFP was stably expressed
under the control of a tissue-speci¢c promoter, MLC2ECFP
ES cells were allowed to di¡erentiate for 5 days within EBs.
EBs were then transferred into a small culture chamber, set on
the stage of an inverted microscope. The di¡erentiation pro-
cess (EB beating and ECFP expression) was recorded on live
cells. Images were acquired for 4 days with a CCD camera in
transmitted light every hour and using the epi£uorescence
light every 3 h. Fig. 1 shows selected images captured on
days 5, 6, 7 and 8. No blue background £uorescence was
detected in round EBs on day 5 (Fig. 1a,g). On day 6, only
a weak ECFP £uorescence was detected (Fig. 1b,h). A di¡use
£uorescence could already be observed on day 7 (Fig. 1c,i).
Patches of £uorescent cells were clearly detected on day 8
(Fig. 1d,j). They overlapped with beating areas of the EBs
recorded in both transmitted and epi£uorescence lights by
video microscopy. This is better seen in higher magni¢cation
images (Fig. 1e,f,k,l). The time courses of expression of ECFP
and MLC2v were well correlated. MLC2v mRNA was already
expressed on day 7, reaching a maximal level on day 12 (Fig.
2a). In order to compare the kinetics of di¡erentiation of the
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MLC2ECFP cells with that of wild type CGR8 cells (mock
cells), several mRNAs of cardiac-speci¢c genes were ampli¢ed
by RT-PCR. In undi¡erentiated CGR8 cells, none of the car-
diac-speci¢c genes GATA4, Nkx2.5, MEF2C, LMHC or
MLC2v was expressed (Fig. 2b). In 5-day-old EBs, GATA4,
Nkx2.5, and MEF2C, three cardiac transcription factors, were
all detected in both wild type (mock) and MLC2ECFP EBs
(Fig. 2b). Expression of transcription factors reached a pla-
teau on day 5 for at least 15 days. Transcripts of LMHC and
MLC2v genes were detected on days 9 and 7, respectively, and
maximal expression was observed on day 12 in both mock
and MLC2ECFP EBs (Fig. 2c).
Spontaneous beating activity of EBs, another indication of
cardiac di¡erentiation, was assessed daily by visual observa-
tion. Spontaneously beating areas were observed in at least
25% of both mock and MLC2ECFP EBs on day 6 (Fig. 3a).
Spontaneous Ca2 spiking was recorded within Fluo3-loaded
EBs on the same day (data not shown). The beating activity
(i.e. number of beating EBs) increased over the next days to
reach a plateau on day 9 (Fig. 3a). Beating areas overlapped
with blue ECFP £uorescent regions in MLC2ECFP EBs (Fig.
3b). The beating frequency of MLC2ECFP EBs on day 9
(1.1 þ 0.2 beats/s, n = 20) was not signi¢cantly di¡erent from
that of mock EBs (1.2 þ 0.2 beats/s, n = 20).
To further assess whether £uorescent areas were speci¢cally
constituted of ventricular myocytes, cells were isolated from
9-day-old EBs and plated for 3 days on glass coverslips. Im-
munostaining using an anti-MLC2v antibody was then carried
out. Fig. 4a shows a merged image of cells expressing blue
ECFP and red MLC2v, visualized by the primary anti-
MLC2v and secondary TRITC-conjugated antibodies.
Clearly, these distinct £uorescence patterns are seen in the
same cells (125 counted cells from three di¡erentiation experi-
ments) showing that ECFP-positive cells also express MLC2v.
On the other hand, an anti-MLC2a antibody combined with a
secondary TRITC-conjugated antibody labelled the myo¢la-
ments of many cells. None of them, however (88 counted cells
from three di¡erentiation experiments), expressed ECFP (Fig.
4b). Fig. 4c shows a merged image of ECFP £uorescence and
of red ryanodine receptor 2 antibody recognized by a speci¢c
antibody and a secondary TRITC-conjugated antibody. The
distribution of ryanodine receptors in ECFP-positive cells was
still not well organized as expected from the poor develop-
ment of the sarcoplasmic reticulum at this stage of develop-
ment. In situ immunostaining in a 9-day-old EB showed that
the MLC2v-positive cells were organized as clusters in which
myo¢brils of individual cells formed an interconnected net-
work (Fig. 4d). Furthermore, a detail of a single cell within
such a network reveals that the regular sarcomeres reached a
length (2 Wm) similar to that of sarcomeres of an adult cardiac
cell, indicating that cells are fully organized at this stage of
development (Fig. 4d, right image).
The exit from the cell cycle is indicative of terminal di¡er-
entiation of cardiac cells and occurs on day 16 in mouse EBs
[31]. An early exit would suggest a possible long-term toxicity
of ECFP. To address this issue, we cultured for 3 days cells
isolated from EBs on day 9 or 13. Incorporation of BrdU into
nuclei revealed that most (72%, out of 105 counted cells in
two separate experiments) of ECFP £uorescent cardiac cells
still underwent DNA synthesis on day 12 (Fig. 5a,c). How-
ever, only a low percentage of ECFP-positive cells (12%, out
of 95 counted cells in two separate experiments) featured
BrdU staining on day 16 (3 days after isolation from EB on
day 13) (Fig. 5c). Most of these cells were multinucleated, an
indicator of cell cycle withdrawal (Fig. 5b). Cells isolated from
9-day-old EBs were also cultured for 3 days in a small culture
chamber on the stage of an inverted microscope. Direct ob-
servation of living cells within 72 h also showed proliferation
of ECFP-positive cells (Fig. 5d).
Fig. 1. Expression of ECFP under the transcriptional control of the
MLC2v promoter in EBs generated from CGR8 ES cells. EBs gen-
erated from the MLC2ECFP CGR8 ES cells were transferred on
day 5 to a culture chamber on the stage of an inverted microscope.
Transmitted light (a,c,e,g,i,k) and £uorescence images (b,d,f,h,j,l)
were captured with a CCD camera on days 5, 6, 7 or 8 at di¡erent
magni¢cations as shown by the scale bar on each image. Beating
areas were observed by video microscopy illuminating the cells with
transmitted light or epi£uorescence. Images e,f,k,l are selected from
the videos. The experiment was repeated four times with similar
time courses.
FEBS 23958 21-7-00 Cyaan Magenta Geel Zwart
N. Meyer et al./FEBS Letters 478 (2000) 151^158 153
4. Discussion
We employed CGR8 ES cells to generate a cell clone ex-
pressing ECFP, a variant of GFP, under the transcriptional
control of the MLC2v promoter. CGR8 cells are derived from
the pluripotent inner cell mass of the preimplantation 129J
mouse embryos. In comparison with other mouse stem cells,
CGR8 cells feature several advantages as an experimental cell
model. First, they do not require feeder cells and are propa-
gated in the presence of LIF under established culture con-
ditions [18]. Second, they di¡erentiate earlier into cardiac cells
than the widely used D3 ES cell line as assessed by the time
course of expression of the MLC2v gene. Therefore, we report
that this ES cell type, which can colonize the germline, when
injected in a blastocyst [25] is suitable to study cardiac cell
di¡erentiation.
MLC2v is the earliest ventricle-speci¢c marker [15]. The 250
bp fragment of the MLC2v promoter used in this study has
been previously characterized [26]. This promoter confers car-
diac ventricular speci¢city in vivo when used to target gene
expression in the ventricle of transgenic mice [27,28].
Although it has been suggested that low levels of transcript
are produced by this promoter fragment [29], we observed a
bright ECFP £uorescence in the EBs and isolated ES-derived
cardioblasts even after 15 passages of the ES MLC2ECFP cell
clone. This suggests that a high number of copies of the re-
porter gene were inserted into the ES genome by cell electro-
poration. This further demonstrates that ES cells have been
Fig. 2. a: RT-PCR of cardiac-speci¢c genes. RNA was extracted from 10 MLC2ECFP EBs on days 5, 7, 9, 12 and 20, and MLC2v mRNA
was ampli¢ed by PCR. The graph on the right presents data from three experiments, performed with three di¡erent cell clones. b,c: Cardiac-
speci¢c genes (GATA4, Nkx2.5, MEF2C, LMHC and MLC2v) were ampli¢ed by RT-PCR from total RNA extracted from ES cells, mock
(left lanes) or MLC2ECFP (right lanes) EBs, on days 5, 7, 9, 12 or 20. The graphs present data from three experiments performed with three
di¡erent cell clones. Data were normalized to the level of expression of tubulin. The DNA 100 bp size marker shows the size of the ampli¢ed
fragments.
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stably transfected. However, we did notice a slight progressive
decrease in ECFP expression in EBs derived from later pas-
sages of ES cells, which encouraged us to use stocks of ES
cells from earlier passages for our further experiments.
To evaluate the e¡ects of ECFP expression on cardiac dif-
ferentiation of ES cells, we ¢rst used RT-PCR to screen ex-
pression of cardiac-speci¢c genes. The earliest markers of car-
diac cell determination (i.e. Nkx2.5, GATA4, MEF2C) were
all turned on in the MLC2ECFP cell clone and appeared with
the same kinetics and to the same extent as in mock cells (Fig.
2). Similarly, the gene of the constitutive contractile protein
MLC2v was expressed as early as day 7. Both MLC2v and
MHC mRNAs were strongly expressed later on day 12. This
is in line with the early detection of ECFP £uorescence, on
day 7 (Fig. 1). That con¢rms that the MLC2v promoter is
turned on at this stage of development in CGR8-derived car-
diac precursors as previously found in ES5 and ES14 cell lines
[30]. It should, however, be noted that expression occurs ear-
lier than in the D3 cell line, in which MLC2v is only detected
on day 9 [16,31]. Furthermore, expression of the ventricular
gene in CGR8-derived cardiac cells in vitro correlates well
with the expression pattern observed in 8-day post-coitum
embryos in vivo [15]. Also, both the extent and the rate of
spontaneous beating activity were similar in ECFP-expressing
EBs and in wild type EBs (Fig. 3). Altogether, these ¢ndings
demonstrate that the ECFP protein does not a¡ect early or
late cardiac cell di¡erentiation. ECFP can thus be used as a
suitable speci¢c marker for cell fate and cardiac autonomic
activity.
In order to determine whether expression driven by the
MLC2v promoter is strictly con¢ned to ventricular precursors
in the EBs, we used RT-PCR and speci¢c antibodies to study
expression of the ventricular- and atrial-speci¢c MLC2v and
MLC2a, respectively. We found that both mRNA of MLC2v
and MLC2a (our unpublished data) and proteins were ex-
pressed in ES-derived cardioblasts within the EBs. However,
only MLC2v but not MLC2a was found in ECFP-positive
cardiac cells derived from the MLC2ECFP ES cells. MLC2v
was seen in organized sarcomeric units, suggesting that ECFP
does not impair myo¢brillogenesis. The MLC2v-expressing
cells seemed to be clustered together forming a network within
the EBs (Fig. 4d). This spatial organization is similar to that
observed in embryonic cardiac explants [32], which further
validates these EBs as a model to study early cardiac develop-
ment.
Finally we report that most ES-derived cardioblasts ex-
pressing ECFP still undergo DNA synthesis on day 12 and
still divide as revealed by supravital microscopy of cells They
withdraw from the cell cycle on day 16 and shift to multi-
nucleation, a characteristic of terminal di¡erentiation (Fig. 5).
The latter events occur with the same kinetics as in mock ES
cells [33]. Therefore, we conclude that expression of ECFP for
Fig. 3. ECFP expression does not a¡ect beating activity. a: In each experiment, 25 mock and 25 MLC2ECFP EBs were observed each day
under the microscope and beating EBs were counted. The ¢gure shows the average ( þ S.E.M.) of four experiments. Data were analyzed with
Student’s t-test. b: Beating activity of a MLC2ECFP EB (day 8) was observed and captured by a CCD camera under transmitted light (left
panel), or epi£uorescent (middle panel). The right panel is the merged picture.
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Fig. 4. ECFP £uorescent cells express MLC2v and ryanodine receptors. a: Merged images of blue image of ECFP-expressing cells and red im-
age of myo¢laments labelled with an anti-MLC2V and secondary TRITC-conjugated anti-rabbit IgG antibody (left picture: 40U objective;
right picture: 100U objective, cells from di¡erent microscope ¢elds). b: Image of an ECFP-negative cell, labelled with a speci¢c anti-MLC2a
antibody combined with a secondary TRITC-conjugated anti-rabbit IgG antibody. c: Merged image of a cell expressing ECFP and labelled
with an anti-ryanodine receptor 2 antibody used with a secondary TRITC-conjugated antibody. d: Immunostaining of cells within a
MLC2ECFP EB using an anti-MLC2v antibody and a TRITC-conjugated secondary antibody. The main picture shows an image restored by
digital deconvolution from 23 successive optical sections. This ¢gure is representative of at least three similar experiments. The right image
shows a single cell inside a network of MLC2v-positive cells. Both images were visualized as shadow projections (Imaris software).
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as long as 8 days (days 7^15) does not a¡ect viability or
mitotic capability of ES-derived ventricular cells.
ES cells with a £uorescent protein as a reporter under the
transcriptional control of a speci¢c ventricular promoter pro-
vide a valuable tool to track the ventricular progenitor cells in
EBs. Since these £uorescent cells still divide on day 12, they
may be easily sorted by FACS analysis after isolation from
the EBs on day 9 and used for experimental cell therapy. The
Fig. 5. Proliferative state of ECFP-expressing cells. EBs were dissociated on day 9 (a,d) or 13 (b) and isolated cells were plated in di¡erentia-
tion medium for 3 days. a,b: BrdU was added to cells for 30 min and then cells were ¢xed. BrdU incorporation was revealed by a monoclonal
antibody, and a secondary TRITC-conjugated anti-mouse IgG antibody (magni¢cation 35U (a) and 55U (b)). ECFP £uorescence allowed the
detection of ventricular myocytes. c: The bar graph shows the number of ECFP-positive cells showing BrdU staining 3 days after cell isolation
from 9- (D12) or 13-day-old EBs (D16). d: Cells isolated on day 9 were transferred to the stage of an inverted microscope and cultured for
3 days. Two ECFP £uorescence images of the same microscope ¢eld were captured at T = 0 (top image) and T+72 h (bottom image).
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cell model can also be used to address speci¢c questions on
how mouse embryonic ventricular cells exit the cell cycle. This
is a crucial situation in the mouse in which cell division dra-
matically decreases after birth [34], a situation similar to that
in the human heart [35]. Our ¢ndings further encourage the
use of a genetically manipulated parental ES cell line to delin-
eate the signalling roads of proliferation, growth and di¡er-
entiation factors that determine the cardiac ventricular phe-
notype. Furthermore, the use of the MLC2ECFP gene
reporter in ES cells derived from transgenic mice may be of
help to understand the causes of lethality in embryos which
die of heart failure after transgenesis.
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